Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The RAS effector RIN1 modulates the formation of aversive memories.

http://www.ncbi.nlm.nih.gov/pubmed/12574403

RAS proteins are critical regulators of mitosis and are mutationally activated in many human tumors. RAS signaling is also known to mediate long-term potentiation (LTP) and long-term memory formation in postmitotic neurons, in part through activation of the RAF-MEK-ERK pathway. The RAS effector RIN1 appears to function through competitive inhibition of RAS-RAF binding and also through diversion of RAS signaling to alternate pathways. We show that RIN1 is preferentially expressed in postnatal forebrain neurons in which it is localized in dendrites and physically associated with RAS, suggesting a role in RAS-mediated postsynaptic neuronal plasticity. Mice with an Rin1 gene disruption showed a striking enhancement in amygdala LTP. In addition, two independent behavioral tests demonstrated elevated amygdala-dependent aversive memory in Rin1(-/-) mice. These results indicate that RIN1 serves as an inhibitory modulator of neuronal plasticity in aversive memory formation.

Pubmed ID: 12574403 RIS Download

Mesh terms: Amygdala | Animals | Carrier Proteins | Cell Count | Conditioning, Classical | Dendrites | Fear | Fetal Viability | Hippocampus | Humans | Intracellular Signaling Peptides and Proteins | Learning | Long-Term Potentiation | Maze Learning | Memory | Mice | Mice, Knockout | Neuronal Plasticity | Neurons | Prosencephalon | Protein Binding | rab GTP-Binding Proteins | ras Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: CA56301
  • Agency: NIMH NIH HHS, Id: MH60919

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.